Usefulness of boger boenninghausen’s characteristics and repertory in homoeopathic management of hyperuricemia by considering rubric uric acid diathesis a prospective single arm pre post clinical study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 35
- 试验地点
- 2
- 主要终点
- It is expected that there will be reduction in serum uric acid level of patients.
研究概览
简要总结
This is an prospective observational study to assess the effect of boger boenninghausen’s characteristics and repertory in homoeopathic management of hyperuricemia by considering rubric uric acid diathesis
Sample size of the study is 35
It is expected that there will be reduction in serum uric acid level of patients.
There will be improvement in patient’s outcome without any substantial medical adverse effect hence a significant reduction in serum uric acid level is expected as compared to baseline and at end of 6 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 59.00 Year(s)（—）
- 性别
- All
入选标准
- •Participants of age group 18-59 year Male with SUA level more than 7 mg/dl and female with more than 6.0 mg/dl Participants willing to give consent will be included Uric acid diathesis as Eliminating Rubric.
排除标准
- •Participants with unstable mental or psychiatric diseases, uncontrolled or severe systemic illnesses, substance abuse, severe endocrine disorders, and already receiving homeopathic treatment for any chronic condition for past 3 months Pregnant and lactating females Recurrent case of renal stone.
结局指标
主要结局
It is expected that there will be reduction in serum uric acid level of patients.
时间窗: 15 months study | Enrollment – 6 months | follow up – 6 months | Statistical analysis – 3 months | first dose after case taking subsequent doses as per follow ups
There will be improvement in patient’s outcome without any substantial medical adverse effect hence a significant reduction in serum uric acid level is expected as compared to baseline and at 6 months.
时间窗: 15 months study | Enrollment – 6 months | follow up – 6 months | Statistical analysis – 3 months | first dose after case taking subsequent doses as per follow ups
次要结局
未报告次要终点
研究者
Dr Anjali Khanai
Bakson Homoeopathic Medical College and Hospital